Citation Impact
Citing Papers
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Synthesis and biological evaluation of immunoconjugates of adriamycin and a human IgM linked by poly[N5-2-hydroxyethyl)-l-glutamine]
1996
Recent advances in the application of solution NMR spectroscopy to multi-span integral membrane proteins
2009
Pancreatic cancer
2004 Standout
Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression
2005
Atopic dermatitis
2003 Standout
XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer
2009
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer
2010
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs
2002
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
An essential role for Rxrα in the development of Th2 responses
2005 StandoutNobel
Evidence for 4-hydroxyalkenals in rat renal cortex peroxidized by N2-methyl-9-hydroxyellipticinium acetate or celiptium®
1990
Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3–dependent signal transduction by phosphorylating human retinoid X receptor α
1999
Nanocarriers for delivery of platinum anticancer drugs
2013
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
2009 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Role of Detergents in Conformational Exchange of a G Protein-coupled Receptor
2012 StandoutNobel
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold – A Potential Therapeutic Intervention for Skin Diseases
2016 StandoutNobel
Structure-based drug screening for G-protein-coupled receptors
2012 StandoutNobel
Chemotherapy and the war on cancer
2005 Standout
Identification of novel prostate‐specific antigen‐binding peptides modulating its enzyme activity
2000
Novel Peptide Inhibitors of Human Kallikrein 2
2006
Hypersensitivity reactions from antineoplastic agents
1987
Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis
1995 Standout
Cardiotoxicity of Chemotherapeutic Agents
2000
Analysis of early failures after intravesical instillation therapy with bacille Calmette‐Guerin for carcinoma in situ of the bladder
1995
The Role of Cockroach Allergy and Exposure to Cockroach Allergen in Causing Morbidity among Inner-City Children with Asthma
1997 Standout
Thermo- and pH-responsive polymers in drug delivery☆
2006 Standout
Glucose-Neopentyl Glycol (GNG) amphiphiles for membrane protein study
2012 StandoutNobel
Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer
2006
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
The role of antisense oligonucleotides in the treatment of bladder cancer
2002
Hypersensitivity reactions from taxol.
1990 Standout
A New Class of Amphiphiles Bearing Rigid Hydrophobic Groups for Solubilization and Stabilization of Membrane Proteins
2012 StandoutNobel
High-throughput drug discovery: What can we expect from HTS?
2005
Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts
1998
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Natural products to drugs: natural product derived compounds in clinical trials
2005
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma
2008
Knocking down barriers: advances in siRNA delivery
2009 Standout
Determining membrane protein structures: still a challenge!
2007
The emerging roles of human tissue kallikreins in cancer
2004
Retinoids: present role and future potential
1999
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
1991 Standout
Polyunsaturated Fatty Acid Deuteration against Neurodegeneration
2020
Camptothecins
2002
Update on tubulin-binding agents
2005
Maltose–neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins
2010 StandoutNobel
Histone lysine methylation and demethylation pathways in cancer
2010
Allergen sensitization through the skin induces systemic allergic responses
2000
The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases
2011 StandoutNobel
RNA Interference-Mediated Gene Silencing of Pleiotrophin Through Polyethylenimine-Complexed Small Interfering RNAs In Vivo Exerts Antitumoral Effects in Glioblastoma Xenografts
2006
Fe-Catalyzed Novel Domino Isomerization/Cyclodehydration of Substituted 2-[(Indoline-3-ylidene)(methyl)]benzaldehyde Derivatives: An Efficient Approach toward Benzo[b]carbazole Derivatives
2014
Iron Catalysis in Organic Synthesis
2015 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Transcriptional regulation of adipogenesis
2000 Standout
The Pharmacology and Clinical Use of Methotrexate
1983
Applications of Deuterium in Medicinal Chemistry
2019
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
1998
Practical Methodologies for the Synthesis of Indoles
2006 Standout
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.
2001
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
2012 Standout
Iterative in Situ Click Chemistry Assembles a Branched Capture Agent and Allosteric Inhibitor for Akt1
2011 StandoutNobel
Divergence of Mechanisms Regulating Respiratory Burst in Blood and Sputum Eosinophils and Neutrophils from Atopic Subjects
2003
The Catalytic Asymmetric Intermolecular Prins Reaction
2021 StandoutNobel
Tandem Facial Amphiphiles for Membrane Protein Stabilization
2010 StandoutNobel
Novel Strategies for the Discovery of Plant-Derived Anticancer Agents
2003
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Sunflower trypsin inhibitor (SFTI-1) analogues of synthetic and biological origin via N→S acyl transfer: potential inhibitors of human Kallikrein-5 (KLK5)
2014 StandoutNobel
Asthma in Non–Inner City Head Start Children
1998
Secretory Phospholipases A2 Activate Selective Functions in Human Eosinophils
2003
Inhibition of Prostate-Specific Antigen (PSA) by α1-Antichymotrypsin: Salt-Dependent Activation Mediated by a Conformational Change
2002
The treatment of soft tissue sarcomas with focus on chemotherapy: A review
1986
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma
1982
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Isolation and Synthesis of Biologically Active Carbazole Alkaloids
2002 Standout
Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer
2002
Cisplatin
1984 Standout
Works of Robert De Jager being referenced
Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen
1999
Long-term complete remission inbladder carcinoma in situ with intravesical tice bacillus Calmette guerin
1991
Enhanced Superoxide Generation by Eosinophils from Asthmatic Children
1991
Phase II clinical trial of DDMP (2,4-diamino-5-(3′,4′-dichlorophenyl)-6-methylpyrimidine) and folinic acid (CF) in solid tumors
1981
A phase II clinical and pharmacokinetic study of intravenous exatecan mesylate (DX-8951f) in patients with untreated metastatic gastric cancer
2005
DX‐8951f: Summary of Phase I Clinical Trials
2000
Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients
2002
Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients
2003
Blood eosinophils, eosinophil‐derived proteins, and leukotriene C4 generation in relation to bronchial hyperreactivity in children with atopic dermatitis
1995
Phase II study of amsacrine in solid tumors: a report of the EORTC early clinical trial-group
1983
Strategies for designing GPCR-focused libraries and screening sets.
2004
E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma
1979
Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells
1996
Phase II study of elliptinium in advanced breast cancer.
1985
Blood eosinophils, leukotriene C4 generation, and bronchial hyperreactivity in formerly preterm infants.
1994
Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia
2018
Randomized phase II study of picoplatin in combination with 5-fluorouracil and leucovorin (FOLPI) as a neuropathy-sparing alternative to modified FOLFOX-6 as first-line therapy for colorectal cancer (CRC)
2009
Current status of cancer immunodetection with radiolabeled human monoclonal antibodies
1993
Phase I and Pharmacokinetic Study of Exatecan Mesylate (DX-8951f): A Novel Camptothecin Analog
2001
Phase I clinical trial and pharmacology of 2,4-diamino-5-(3′,4′-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF)
1981
Phase I and Pharmacokinetics (PK) of DJ-927, an oral taxane, in patients (Pts) with advanced cancers
2004
Phase II study of 9-hydroxy-2N-methylellipticinium acetate
1984